Similar articles

• Effects of transdermal scopolamine, alone or in combination with cimetidine, on total 24 hour gastric acid secretion in patients with duodenal ulcer.

  Richardson CT, Feldman M. Richardson CT, et al. Gut. 1986 Dec;27(12):1493-7. doi: 10.1136/gut.27.12.1493. Gut. 1986. PMID: 3804025 Free PMC article. Clinical Trial.
• Transdermal scopolamine and basal acid secretion.

  Gleiter CH, Antonin KH, Brodrick T, Bieck PR, Breucha G. Gleiter CH, et al. N Engl J Med. 1984 Nov 22;311(21):1378. doi: 10.1056/NEJM198411223112113. N Engl J Med. 1984. PMID: 6493293 Clinical Trial. No abstract available.
• Transdermal scopolamine as treatment of bradyarrhythmias.

  Salas Nieto J, Ruiperez Abizanda JA, Pico Aracil F, de la Morena Valenzuela G, Ruiz Ros JA. Salas Nieto J, et al. Chest. 1992 Jun;101(6):1588-90. doi: 10.1378/chest.101.6.1588. Chest. 1992. PMID: 1600776
• Transdermal scopolamine use for post-rhytidectomy sialocele.

  Lapid O, Kreiger Y, Sagi A. Lapid O, et al. Aesthetic Plast Surg. 2004 Jan-Feb;28(1):24-8. doi: 10.1007/s00266-004-3115-5. Epub 2004 May 3. Aesthetic Plast Surg. 2004. PMID: 15116278 Review.
• Transdermal therapeutic systems and rate controlled drug delivery.

  Yum SI. Yum SI. Med Prog Technol. 1989;15(1-2):47-52. Med Prog Technol. 1989. PMID: 2530425 Review.